220 related articles for article (PubMed ID: 33856527)
1. Caucasians with acral lentiginous melanoma have the same outcome as patients with stage- and limb-matched superficial spreading melanoma.
Susok L; Gambichler T
J Cancer Res Clin Oncol; 2022 Feb; 148(2):497-502. PubMed ID: 33856527
[TBL] [Abstract][Full Text] [Related]
2. Acral Lentiginous Melanoma: Incidence and Survival in the United States, 2006-2015, an Analysis of the SEER Registry.
Huang K; Fan J; Misra S
J Surg Res; 2020 Jul; 251():329-339. PubMed ID: 32208196
[TBL] [Abstract][Full Text] [Related]
3. Clinical presentation, histology, and prognoses of malignant melanoma in ethnic Chinese: a study of 522 consecutive cases.
Chi Z; Li S; Sheng X; Si L; Cui C; Han M; Guo J
BMC Cancer; 2011 Feb; 11():85. PubMed ID: 21349197
[TBL] [Abstract][Full Text] [Related]
4. Sentinel Lymph Node Biopsy Positivity in Patients With Acral Lentiginous and Other Subtypes of Cutaneous Melanoma.
Cheraghlou S; Ugwu N; Girardi M
JAMA Dermatol; 2022 Jan; 158(1):51-58. PubMed ID: 34878492
[TBL] [Abstract][Full Text] [Related]
5. Tumor infiltrating lymphocytes in acral lentiginous melanoma: a study of a large cohort of cases from Latin America.
Castaneda CA; Torres-Cabala C; Castillo M; Villegas V; Casavilca S; Cano L; Sanchez J; Dunstan J; Calderon G; De La Cruz M; Cotrina JM; Gomez HL; Galvez R; Abugattas J
Clin Transl Oncol; 2017 Dec; 19(12):1478-1488. PubMed ID: 28577153
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of acral lentiginous histologic type in T1 melanoma.
Mejbel HA; Torres-Cabala CA; Milton DR; Ivan D; Feldmeyer L; Namikawa K; Nagarajan P; Tetzlaff MT; Curry JL; Ross MI; Hwu WJ; Prieto VG; Aung PP
Mod Pathol; 2021 Mar; 34(3):572-583. PubMed ID: 32759976
[TBL] [Abstract][Full Text] [Related]
7. Acral lentiginous melanoma: incidence and survival patterns in the United States, 1986-2005.
Bradford PT; Goldstein AM; McMaster ML; Tucker MA
Arch Dermatol; 2009 Apr; 145(4):427-34. PubMed ID: 19380664
[TBL] [Abstract][Full Text] [Related]
8. Acral lentiginous melanoma versus other melanoma: A single-center analysis in Japan.
Wada M; Ito T; Tsuji G; Nakahara T; Hagihara A; Furue M; Uchi H
J Dermatol; 2017 Aug; 44(8):932-938. PubMed ID: 28342269
[TBL] [Abstract][Full Text] [Related]
9. High density of M2-macrophages in acral lentiginous melanoma compared to superficial spreading melanoma.
Zúñiga-Castillo M; Pereira NV; Sotto MN
Histopathology; 2018 Jun; 72(7):1189-1198. PubMed ID: 29415335
[TBL] [Abstract][Full Text] [Related]
10. Acral lentiginous melanoma: Clinicopathologic and survival differences according to tumour location.
Howard M; Xie C; Wee E; Wolfe R; McLean C; Kelly JW; Pan Y
Australas J Dermatol; 2020 Nov; 61(4):312-317. PubMed ID: 32363586
[TBL] [Abstract][Full Text] [Related]
11. Acral cutaneous melanoma in caucasians: clinical features, histopathology and prognosis in 112 patients.
Kuchelmeister C; Schaumburg-Lever G; Garbe C
Br J Dermatol; 2000 Aug; 143(2):275-80. PubMed ID: 10951133
[TBL] [Abstract][Full Text] [Related]
12. [Is acrolentiginous melanoma (ALM) more malignant than superficially spreading melanoma (SSM) at a high-risk site? A matched-pair comparison between 113 ALM and SSM within the scope of a multicenter study].
Breuninger H; Köhler C; Drepper H; Bastian B; Bröcker EB; Göhl J; Groth W; Hermanek P; Hohenberger W; Lippold A
Hautarzt; 1994 Aug; 45(8):529-31. PubMed ID: 7960751
[TBL] [Abstract][Full Text] [Related]
13. "Gloves-and-socks" melanoma: does histology make a difference?
Soudry E; Gutman H; Feinmesser M; Gutman R; Schachter J
Dermatol Surg; 2008 Oct; 34(10):1372-8. PubMed ID: 18616532
[TBL] [Abstract][Full Text] [Related]
14. Melanoma: differences between Asian and Caucasian patients.
Lee HY; Chay WY; Tang MB; Chio MT; Tan SH
Ann Acad Med Singap; 2012 Jan; 41(1):17-20. PubMed ID: 22499476
[TBL] [Abstract][Full Text] [Related]
15. Clinical features and prognosis of Asian patients with acral lentiginous melanoma who have nodal nevi in their sentinel lymph node biopsy specimen.
Kim HJ; Seo JW; Roh MS; Lee JH; Song KH
J Am Acad Dermatol; 2018 Oct; 79(4):706-713. PubMed ID: 29673774
[TBL] [Abstract][Full Text] [Related]
16. Acral lentiginous melanoma-Population, treatment, and survival using the NCDB from 2004 to 2015.
Bian SX; Hwang L; Hwang J; Ragab O; In GK; Peng D; Lin E
Pigment Cell Melanoma Res; 2021 Nov; 34(6):1049-1061. PubMed ID: 34273249
[TBL] [Abstract][Full Text] [Related]
17. Acral lentiginous melanoma histotype predicts outcome in clinical stage I-II melanoma patients: an International multicenter study.
Mandalà M; Rutkowski P; Galli F; Patuzzo R; De Giorgi V; Rulli E; Gianatti A; Valeri B; Merelli B; Szumera-Ciećkiewicz A; Massi D; Maurichi A; Teterycz P; Santinami M
ESMO Open; 2022 Jun; 7(3):100469. PubMed ID: 35421840
[TBL] [Abstract][Full Text] [Related]
18. National Comprehensive Analysis of Characteristics of Acral Lentiginous Melanoma.
Huayllani MT; Restrepo DJ; Boczar D; Avila FR; Bagaria SP; Spaulding AC; Rinker BD; Forte AJ
Anticancer Res; 2020 Jun; 40(6):3411-3415. PubMed ID: 32487638
[TBL] [Abstract][Full Text] [Related]
19. Acral lentiginous melanoma: who benefits from sentinel lymph node biopsy?
Ito T; Wada M; Nagae K; Nakano-Nakamura M; Nakahara T; Hagihara A; Furue M; Uchi H
J Am Acad Dermatol; 2015 Jan; 72(1):71-7. PubMed ID: 25455840
[TBL] [Abstract][Full Text] [Related]
20. Does sentinel lymph node status have prognostic significance in patients with acral lentiginous melanoma?
Pavri SN; Han G; Khan S; Han D
J Surg Oncol; 2019 Jun; 119(8):1060-1069. PubMed ID: 30883783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
